InvestorsHub Logo
Followers 34
Posts 2484
Boards Moderated 0
Alias Born 02/04/2013

Re: None

Friday, 04/14/2023 6:46:31 AM

Friday, April 14, 2023 6:46:31 AM

Post# of 461409
This is bizarre. Any thoughts as to why this would be taking place now.


Anavex Life Sciences Corp.
HISTORY TOOLS
CIK: 1314052 Ticker: AVXL

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC

Date of Report (Date of earliest event reported): April 11, 2023

ANAVEX LIFE SCIENCES CORP.
(Exact name of registrant as specified in its charter)

Nevada 001-37606 98-0608404
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)

630 5th Avenue
20th Floor
New York, NY 10111

Emerging growth company ?

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On April 11, 2023, the Board of Directors (the “Board”) of Anavex Life Sciences Corp., a Nevada corporation (the “Company”), determined that it was in the best interests of the Company and its stockholders to amend and restate the Company’s Bylaws, and approved and adopted the Amended and Restated Bylaws of the Company (the “Amended and Restated Bylaws”). The Board amended the Company’s Bylaws to require that the position of Chairman of the Board of Directors must be filled by an independent director and cannot be held by the Chief Executive Officer of the Company. The Amended and Restated Bylaws became effective immediately upon their adoption.

The foregoing summary of the Amended and Restated Bylaws does not purport to be a complete statement of the terms of such document and is qualified in its entirety by reference to the full text the Amended and Restated Bylaws, a copy of which is filed herewith as Exhibit 3.1 to this Current Report on Form 8-K.

Item 9.01. Financial Statements and Exhibits.

Exhibit No.

Description

Exhibit 3.1 Amended and Restated Bylaws
Exhibit 104 Cover Page Interactive Data File




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ANAVEX LIFE SCIENCES CORP.

By:
/s/ Christopher Missling
Name: Christopher Missling, PhD
Title: Chief Executive Officer
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News